A low-dose cream, tablet or ring that many postmenopausal women have never heard of is now associated with something more consequential than comfort. New analysis links vaginal estrogen prescriptions in women with recurrent urinary tract infections to lower rates of sepsis, hospitalization and death over the following years.
The finding, published in the journal Urology and reported by CIDRAP, draws on a large real-world database of electronic health records rather than a clinical trial. That distinction matters and is addressed below.
